C12N 2750/10051
Methods of production or purification of viral material
C12N2750/10051 (Methods of production or purification of viral material) appears on 71 US grants and 107 published applications in this corpus.
Search patents in C12N- Granted patents
- 71
- Published applications
- 107
- Assignees
- 30
- Inventors
- 91
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 2 | 4 |
| 2005 | 0 | 3 |
| 2006 | 1 | 3 |
| 2007 | 7 | 10 |
| 2008 | 6 | 11 |
| 2009 | 3 | 10 |
| 2010 | 10 | 15 |
| 2011 | 4 | 6 |
| 2012 | 1 | 3 |
| 2013 | 2 | 2 |
| 2014 | 2 | 2 |
| 2015 | 3 | 7 |
| 2016 | 1 | 4 |
| 2017 | 6 | 4 |
| 2018 | 9 | 4 |
| 2019 | 2 | 2 |
| 2020 | 3 | 1 |
| 2021 | 1 | 4 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 3 | 3 |
| 2025 | 2 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- PCV2 ORF2 protein variant and virus like particles composed thereof11 Mar 2025US 12,247,051 B2
- Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same3 Dec 2024US 12,156,907 B2Bioapplications Inc.
- Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof13 Feb 2024US 11,896,659 B2
- PCV2 ORF2 protein variant and virus like particles composed thereof2 Jan 2024US 11,858,963 B2
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof12 Mar 2026US 2026/0069672 A1Boehringer Ingelheim Vetmedica GmbH
- Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use30 Oct 2025US 2025/0332242 A1Zoetis Services LLC
- Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines30 Oct 2025US 2025/0332243 A1Zoetis Services LLC
- Pcv2 orf2 protein variant and virus like particles composed thereof31 Jul 2025US 2025/0243246 A1Boehringer Ingelheim Animal Health USA Inc.
- Self-replicating dna expression system and immunogen17 Oct 2024US 2024/0344100 A1
Most cited
By later US patents
- Circovirus sequences associated with piglet weight loss disease (PWD)84US 6,703,023 B1Agence Francaise De Securite Sanitaire Des Aliments · 2004
- Circovirus sequences associated with piglet weight loss disease (PWD)66US 7,223,594 B2Wyeth · 2007
- Methods to culture circovirus65US 6,794,163 B2University of Saskatchewan · 2004
- Circovirus sequences associated with piglet weight loss disease (PWD)63US 7,148,015 B2Wyeth · 2006
- Circovirus sequences associated with piglet weight loss disease (PWD)63US 7,244,433 B2Wyeth · 2007